Effects of Long-term Dapagliflozin Treatment on Hemorheology, Leukocyte Activation and Oxidative Stress
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2019
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Jul 2017 Status changed from not yet recruiting to recruiting.
- 06 Feb 2017 New trial record